ITMI922826A0 - Composizione farmaceutica a rilascio controllato in sospensione liquida - Google Patents

Composizione farmaceutica a rilascio controllato in sospensione liquida

Info

Publication number
ITMI922826A0
ITMI922826A0 IT92MI2826A ITMI922826A ITMI922826A0 IT MI922826 A0 ITMI922826 A0 IT MI922826A0 IT 92MI2826 A IT92MI2826 A IT 92MI2826A IT MI922826 A ITMI922826 A IT MI922826A IT MI922826 A0 ITMI922826 A0 IT MI922826A0
Authority
IT
Italy
Prior art keywords
pharmaceutical composition
controlled release
liquid suspension
suspension
liquid
Prior art date
Application number
IT92MI2826A
Other languages
English (en)
Inventor
Giancarlo Santus
Ettore Bilato
Giuseppe Bottoni
Original Assignee
Recordati Chem Pharm
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Recordati Chem Pharm filed Critical Recordati Chem Pharm
Publication of ITMI922826A0 publication Critical patent/ITMI922826A0/it
Priority to ITMI922826A priority Critical patent/IT1256651B/it
Priority to EP93119587A priority patent/EP0601508B1/en
Priority to DE69324214T priority patent/DE69324214T2/de
Priority to ES93119587T priority patent/ES2132163T3/es
Priority to SG1996004299A priority patent/SG54207A1/en
Priority to AT93119587T priority patent/ATE178209T1/de
Priority to JP5310680A priority patent/JPH06279274A/ja
Priority to US08/165,307 priority patent/US5527545A/en
Publication of ITMI922826A1 publication Critical patent/ITMI922826A1/it
Priority to US08/482,092 priority patent/US5670171A/en
Application granted granted Critical
Publication of IT1256651B publication Critical patent/IT1256651B/it

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/192Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ITMI922826A 1989-09-18 1992-12-11 Composizione farmaceutica a rilascio controllato in sospensione liquida IT1256651B (it)

Priority Applications (9)

Application Number Priority Date Filing Date Title
ITMI922826A IT1256651B (it) 1992-12-11 1992-12-11 Composizione farmaceutica a rilascio controllato in sospensione liquida
SG1996004299A SG54207A1 (en) 1992-12-11 1993-12-06 Liquid-suspension controlled-release pharmaceutical composition
DE69324214T DE69324214T2 (de) 1992-12-11 1993-12-06 Pharmazeutische flüssige Suspensionszusammensetzung mit kontrollierter Freigabe
ES93119587T ES2132163T3 (es) 1992-12-11 1993-12-06 Composicion farmaceutica de liberacion controlada en forma de suspension liquida.
EP93119587A EP0601508B1 (en) 1992-12-11 1993-12-06 Liquid-suspension controlled-release pharmaceutical composition
AT93119587T ATE178209T1 (de) 1992-12-11 1993-12-06 Pharmazeutische flüssige suspensionszusammensetzung mit kontrollierter freigabe
JP5310680A JPH06279274A (ja) 1992-12-11 1993-12-10 懸濁液徐放性製薬組成物
US08/165,307 US5527545A (en) 1989-09-18 1993-12-10 Liquid-suspension controlled-release pharmaceutical composition
US08/482,092 US5670171A (en) 1989-09-18 1995-06-07 Liquid-suspension controlled-release pharmaceutical composition

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI922826A IT1256651B (it) 1992-12-11 1992-12-11 Composizione farmaceutica a rilascio controllato in sospensione liquida

Publications (3)

Publication Number Publication Date
ITMI922826A0 true ITMI922826A0 (it) 1992-12-11
ITMI922826A1 ITMI922826A1 (it) 1994-06-11
IT1256651B IT1256651B (it) 1995-12-12

Family

ID=11364448

Family Applications (1)

Application Number Title Priority Date Filing Date
ITMI922826A IT1256651B (it) 1989-09-18 1992-12-11 Composizione farmaceutica a rilascio controllato in sospensione liquida

Country Status (7)

Country Link
EP (1) EP0601508B1 (it)
JP (1) JPH06279274A (it)
AT (1) ATE178209T1 (it)
DE (1) DE69324214T2 (it)
ES (1) ES2132163T3 (it)
IT (1) IT1256651B (it)
SG (1) SG54207A1 (it)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1270216B (it) * 1994-06-14 1997-04-29 Recordati Chem Pharm Metodo di stabilizzazione di composti biologicamente attivi mediante microgranuli ricoperti sospendibili in fluidi alimentari
GB9611328D0 (en) * 1996-05-31 1996-08-07 Zeneca Ltd Pharmaceutical compositions
DE19648576C2 (de) * 1996-11-23 1999-08-12 Lohmann Therapie Syst Lts Lutschtablette zur modifizierten Freisetzung von Wirkstoffen im Gastrointestinaltrakt
CN1158071C (zh) * 1997-05-30 2004-07-21 渗透有限公司 多层渗透装置
SE9903879D0 (sv) * 1999-10-28 1999-10-28 Ethical Pharmaceuticals Sweden Multipor food protection
FR2822834B1 (fr) 2001-04-02 2005-02-25 Flamel Tech Sa Suspension colloidale de nanoparticules a base de copolymeres amphiphile pour la vectorisation de principes actifs et leur mode de preparation
US8101209B2 (en) 2001-10-09 2012-01-24 Flamel Technologies Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles
FR2837100B1 (fr) * 2002-03-18 2004-07-23 Flamel Tech Sa Comprimes a bases de microcapsules a liberation modifiee
FR2843881B1 (fr) * 2002-09-02 2006-06-02 Flamel Tech Sa Formulation pharmaceutique orale sous forme de suspension aqueuse de microcapsules permettant la liberation modifiee de principe(s) actif(s)
CA2480824A1 (fr) 2002-04-09 2003-10-16 Flamel Technologies Formulation pharmaceutique orale sous forme de suspension aqueuse de microcapsules permettant la liberation modifiee d'amoxicilline
WO2003084518A2 (fr) 2002-04-09 2003-10-16 Flamel Technologies Suspension orale de microcapsules de principes actifs
FR2843117B1 (fr) 2002-07-30 2004-10-15 Flamel Tech Sa Polyaminoacides fonctionnalises par au moins un groupement hydrophobe et leurs applications notamment therapeutiques
FR2860516B1 (fr) 2003-10-03 2006-01-13 Flamel Tech Sa Homopolyaminoacides telecheliques fonctionnalises par des groupements hydrophobes et leurs applications notamment therapeutiques
FR2862536B1 (fr) 2003-11-21 2007-11-23 Flamel Tech Sa Formulations pharmaceutiques pour la liberation prolongee de principe(s) actif(s), ainsi que leurs applications notamment therapeutiques
EP1765305A4 (en) * 2004-07-09 2008-06-04 Drugtech Corp REGULATED PHASE COMPOSITION TECHNOLOGY USED AS ENHANCED MEDICATION PROTECTION METHOD
US10258583B2 (en) * 2014-05-01 2019-04-16 Sun Pharmaceutical Industries Limited Extended release liquid compositions of guanfacine
US20180104197A9 (en) 2014-05-01 2018-04-19 Sun Pharmaceutical Industries Limited Extended release liquid compositions of metformin
RU2016147009A (ru) 2014-05-01 2018-06-04 Сан Фармасьютикал Индастриз Лимитед Композиции с пролонгированным высвобождением в виде суспензии
US9962336B2 (en) 2014-05-01 2018-05-08 Sun Pharmaceutical Industries Limited Extended release suspension compositions
US10285908B2 (en) 2014-07-30 2019-05-14 Sun Pharmaceutical Industries Ltd Dual-chamber pack
US10238803B2 (en) 2016-05-02 2019-03-26 Sun Pharmaceutical Industries Limited Drug delivery device for pharmaceutical compositions

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4571333A (en) * 1983-06-14 1986-02-18 Syntex (U.S.A.) Inc. Controlled release naproxen and naproxen sodium tablets
EP0178299A4 (en) * 1984-03-21 1987-04-28 Key Pharma DOSAGE FORM FOR NAPROXYN FOR PERMANENT ADMINISTRATION IN THE MOUTH.
IE58110B1 (en) * 1984-10-30 1993-07-14 Elan Corp Plc Controlled release powder and process for its preparation
IT1231410B (it) * 1987-09-22 1991-12-04 Cooperativa Farmaceutica Composizione farmaceutica antiinfiammatoria ad effetto prolungato per uso topico
GB8724763D0 (en) * 1987-10-22 1987-11-25 Aps Research Ltd Sustained-release formulations
IT1226940B (it) * 1988-09-16 1991-02-22 Recordati Chem Pharm Sistema terapeutico a rilascio controllato per formulazioni farmaceutiche liquide
IE902829A1 (en) * 1989-08-14 1991-02-27 Eurand America Microencapsulated taste-masked water-insoluble nsaid drug¹materials
IE66933B1 (en) * 1990-01-15 1996-02-07 Elan Corp Plc Controlled absorption naproxen formulation for once-daily administration

Also Published As

Publication number Publication date
EP0601508B1 (en) 1999-03-31
EP0601508A3 (en) 1995-10-25
IT1256651B (it) 1995-12-12
JPH06279274A (ja) 1994-10-04
EP0601508A2 (en) 1994-06-15
ES2132163T3 (es) 1999-08-16
ITMI922826A1 (it) 1994-06-11
ATE178209T1 (de) 1999-04-15
DE69324214T2 (de) 1999-08-19
DE69324214D1 (de) 1999-05-06
SG54207A1 (en) 1998-11-16

Similar Documents

Publication Publication Date Title
ITMI922826A0 (it) Composizione farmaceutica a rilascio controllato in sospensione liquida
ITMI941410A0 (it) Composizione farmaceutica a rilascio controllato di moguisteina in sospensione liquida
BR9307025A (pt) Composição liquida estruturada estável
DK0556056T3 (da) Trokar med gennemsigtig kanyle
DE69327152T2 (de) Flüssigkristallzusammensetzung
GB8827081D0 (en) Display/storage system
BR9203194A (pt) Composicao de tinta liquida
ZA903409B (en) Maleinimide-derivatives and their use as pharmaceuticals
PL298260A1 (en) Reflective member in particular for road marking purposes
DE69107566D1 (de) Flurförderfahrzeug mit Fahrerstandplatz und erhöhter Stabilität.
GB2221690B (en) Liquid crystal materials
GB8826249D0 (en) Display means
EP0447168A3 (en) Long acting granular pharmaceutical composition
GB2249794B (en) Liquid crystal materials
GB2279871B (en) Drug retention systems for use in aquaculture
HK103497A (en) Pyrimidine derivative and liquid crystal composition incorporating the same
DE9213242U1 (de) Infusionsflaschenständer
GB2235192B (en) Difluorophenyl esters and their use as liquid crystal materials
GB2249795B (en) Liquid crystal materials
NO920032D0 (no) Farmasoeytiske blandinger med kontinuerlig frigjoering
RO105558B1 (ro) Masina de lustruit cu banda
KR910010892U (ko) 하체부분이 좌우로 움직이는 상품 전시용 마네킹
DE9316068U1 (de) Display-Paletten-System mit Seitenstützen
PH24946A (en) Heteroarylcarboxamide derivatives and pharmaceutical composition containing the same
HU9200275D0 (en) Structure for placing the constructions built in roads

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19961230